RDY 453 (Venlafaxine Hydrochloride Extended Release 37.5 mg)

Pill with imprint RDY 453 is Gray & Pink, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 37.5 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Venlafaxine is used in the treatment of anxiety; autism; major depressive disorder; generalized anxiety disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 453

Venlafaxine Hydrochloride Extended Release

Imprint

RDY 453

Strength

37.5 mg

Color

Gray & Pink

Size

16.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Serotonin-norepinephrine reuptake inhibitors

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Dr. Reddy's Laboratories Ltd.

National Drug Code (NDC)

55111-0453

Inactive Ingredients

dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer, ethylcelluloses, gelatin, medium-chain triglycerides, microcrystalline cellulose, povidone, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferrosoferric oxide, ferric oxide yellow, potassium hydroxide, propylene glycol, shellac, ammonia

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer